UPDATE: Lion to Gobble NetGenics for $17M; Deal Would Marry Bio and Chem Data | GenomeWeb

NEW YORK, Jan. 15 - Lion Bioscience plans to acquire NetGenics for approximately $17 million in stock, both firms announced on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.